Evaluation of Different Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell Disease
Clinical trial NCT01987908 · TERMINATED
Trial details
- NCT number
- NCT01987908
- Sponsor
- Baxalta now part of Shire
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-03
- Primary completion
- 2015-03-16
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.